The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2024 OMIG Meeting Agenda

Ocular Microbiology and Immunology Group
58th Annual Meeting
October 18, 2024


Moderators:
Jennifer Rose-Nussbaumer, MD, and Bhupesh Bagga, DOMS, FRCS

NOTE: All times are CENTRAL STANDARD TIME

CLICK on titles to view abstracts
6:45 a.m.
Registration

7:30 a.m.
Introduction by Moderators

7:35 a.m.


2023 Harry Hirsch Leiter Award Recipient:

Efficacy of a Novel Antibiotic Drug Combination Towards Multi-Drug Resistant Ocular Pathogens

Rachel Wozniak, MD, PhD  
7:42 a.m.


1. Cefiderocol is Effective against Numerous Gram-Negative Keratitis Isolates In Vitro

Jonathan B. Mandell, MS, PhD
7:49 a.m.


2. Automated Detection of Bacterial Keratitis on Whole Slide Images of Gram Stains Using Dual Stream Multiple Instance Learning

Jad F. Assaf, MD

7:56 a.m.
3. Identifying the Ocular Surface Microbiome and Immune Cells in Healthy Subjects
Simran Mangwani-Mordani, MD, MSc
8:03 a.m.
4. Clinical and Genomic Profile of Antimicrobial Resistance Among Bacterial Keratitis Isolates at Johns Hopkins
Nakul Shekhawat, MD, MPH
8:10 a.m.
5. Adaptive Nanopore Sequencing for Rapid Diagnosis of Infectious Keratitis
Marcus Toral, MD, PhD
8:17 a.m.


6. Seasonal Hyperacute Panuveitis (SHAPU) is Associated with Streptococcus pneumonia Infection

Kenji Nakamichi

8:24 a.m.


7. Long-Term Graft Survival after Rose Bengal Photodynamic Antimicrobial Therapy for Infectious Keratitis and Keratoplasty

Jordan J. Huang, MD

8:31 a.m.


8. Rose Bengal Photodynamic Therapy (PDAT) for Mycobacterium abscessus Keratitis: In Vitro Efficacy and Clinical Outcomes

Salomon Merikansky, MD

8:38 a.m.


9. Association of weather variables with pathogens contributing to conjunctivitis worldwide

Daisy Yan, MPH

8:45 a.m.


10. Comparison of Pain Interference on Quality of Life in Neuropathic Corneal Pain (NCP) and Dry Eye Disease (DED) Patients with and without Non-ocular Facial Pain

Leyla Mirzaee, DMSc

8:52 a.m.


11. Neurotrophic keratitis may have an Underlying Inflammatory or Autoimmune Etiology

Ana Balbuena-Pareja, MSc

8:59 a.m.


12. Alternative Photosensitizer Evaluation in fungal keratitis: In vitro Inhibition and Bbiophysical Profile Analysis

James Lai  
9:06 a.m.


13. Moved to Poster Presentaton


9:13 a.m.


14. Prediction of Subepithelial Infiltrates (SEI) following adenovirus D8 keratoconjunctivitis via Machine Learning

Behrouz Rahimi, MD

9:20 a.m.


BREAK and Posters


9:45 a.m.


15. Clinico - molecular Analysis of Patients with microbial keratitis Showing Unusual Oval or Spherical Structures in Direct Microscopic Examination of Corneal Scraping

Savitri Sharma, MD
9:52 a.m.


16. Topical Tacrolimus as Adjunctive Therapy in Mycotic Corneal Ulcers-A Pilot Study

Kunal Mandlik, MD
9:59 a.m
17. Evaluation of the Ocular Surface Epithelium Using Artificial Intelligence and High-Resolution Anterior Segment Optical Coherence Tomography
Jason A. Greenfield, BA

10:06 a.m.


18. Infectious Etiologies of Conjunctival Tumors

Michael Antonietti, BS

10:13 a.m.


19. IL-6 Amplifies Alloimmunity by Inducing Dysfunctional IFN-γ Secreting Treg through the VEGFA-VEGFR1 Axis

Seokjoo Lee, PhD, DSc

10:20 a.m.


20. In vivo TNFRSF25 and IL-2R Stimulation in Mice Induces a Regulatory Environment within Multiple Tissues including the Ocular Adnexa that are Frequent Targets of GVHD

Duneia McManus

10:27 a.m.


21. Host immunomodulatory metabolite RvD1 as Anti-inflammatory Therapies to Treat Infectious and Non-infectious Ocular Diseases  

Ashok Kumar, PhD

10:34 a.m.


22. Harnessing the Power of Macrophage Secretome to Combat Corneal Scarring Following microbial keratitis

Gink Yang, PhD

10:41 a.m.
23. Role of T Regulatory Cells in Modulating Angiogenesis in a Murine Model of Diabetic Corneal Neovascularization
Dr. Francesca Kahale
10:48 a.m.
BREAK and Posters

11:15 a.m.
Introduction -- Thygeson Lecture


Thygeson Lecture: "Will the Last Case of Trachoma Please Stand Up?"
Thomas Lietman, MD
Ruth Lee and Phillips Thygeson Distinguished Professor
Department of Ophthalmology and Department of Epidemiology & Biostatistics and Director, Francis I. Proctor Foundation
University of California, San Francisco
San Francisco, California

11:55 a.m. Questions, Closing Comments, Awards
12:00 p.m. Adjourn
12:15 p.m.

Business Luncheon - Huron Room (2nd floor)

Top of Page


 

 

space